Back to News
Market Impact: 0.2
Bausch Health Companies Consensus Price Target Increased by 11.58% to $7.29
Source: Nasdaq
Analyst EstimatesAnalyst Insights
The average one-year analyst price target for Bausch Health Companies was revised up 11.58% to $7.29 per share from $6.54 on October 22, 2026. The figures are aggregate analyst targets compiled by Fintel; the article provides no share-price reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
BHC0.30
More News
- Five TSX Stocks Finished Well Ahead of the Composite in a Week of Results and a Rate Hike
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Reliance’s Record $19 Billion Surge Lifts Nifty, Keeps India Bulls in the Game
- Apple reports after the bell. Options traders expect a big move
- Mizuho lowers Lumentum stock price target on Marvell acquisition
- Why is Apple stock falling afterhours today?